Nitric oxide synthase (NOS) (NOS)

The term "Nitric oxide pathway mediator" is not a specific molecule or receptor but refers broadly to components involved in the nitric oxide (NO) signaling cascade. The central mediators are nitric oxide synthases—enzymes that catalyze the production of nitric oxide from L‐arginine. There are three main isoforms: neuronal NOS (nNOS, NOS1), inducible NOS (iNOS, NOS2), and endothelial NOS (eNOS, NOS3). These enzymes regulate diverse physiological processes including vasodilation, neurotransmission, immune defense mechanisms, and cellular apoptosis. Nitric oxide itself acts as a short-lived gaseous messenger that diffuses across membranes to activate soluble guanylate cyclase in target cells. This leads to increased cyclic GMP production and subsequent activation of protein kinase G pathways responsible for smooth muscle relaxation and other effects. Dysregulation or altered expression/activity within this pathway is implicated in cardiovascular diseases such as hypertension and atherosclerosis; it also plays roles in cancer progression, inflammation control, neurodegeneration, erectile dysfunction, and more. Therapeutic agents targeting this system include direct NO donors like nitroglycerin for angina relief; phosphodiesterase inhibitors like sildenafil which potentiate downstream cGMP effects; and experimental modulators aimed at specific isoforms for inflammatory or neurodegenerative conditions. Because "Nitric oxide pathway mediator" does not refer to one defined molecular entity but rather an entire class/pathway involving multiple enzymes/receptors/signaling molecules—and because it lacks specificity—it should be considered an incorrect/ambiguous target name when seeking structured drug-target information.[1][2][3][4]

Other names

Nitric oxide pathwayNO pathwayNOS pathwayNitric oxide signalingNO signaling

Activation of soluble guanylate cyclase to increase cGMP levels leading to smooth muscle relaxation[3][4] - S-nitrosylation of target proteins affecting their function[2][7] - Modulation of immune cell activity via iNOS induction[2]